Cite

HARVARD Citation

    Martens, P. et al. (2018). Effects of intravenous home dobutamine in palliative end‐stage heart failure on quality of life, heart failure hospitalization, and cost expenditure. ESC heart failure. pp. 562-569. [Online]. 
  
Back to record